BARCLAYS PLC - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 209 filers reported holding REATA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.53 and the average weighting 0.6%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$8,057
+429.0%
79,034
+371.7%
0.01%
+400.0%
Q1 2023$1,523
+152.6%
16,756
+5.6%
0.00%
Q4 2022$603
-99.8%
15,870
+14.5%
0.00%
Q3 2022$348,000
-26.7%
13,862
-11.3%
0.00%
Q2 2022$475,000
-49.9%
15,631
-45.9%
0.00%
-100.0%
Q1 2022$948,000
-70.5%
28,910
-76.3%
0.00%0.0%
Q4 2021$3,214,000
+24.3%
121,782
+373.9%
0.00%0.0%
Q3 2021$2,585,000
+273.0%
25,699
+424.7%
0.00%
Q2 2021$693,000
-11.6%
4,898
-37.7%
0.00%
Q1 2021$784,000
+211.1%
7,857
+285.0%
0.00%
Q4 2020$252,000
+10.0%
2,041
-12.9%
0.00%
Q3 2020$229,000
-95.5%
2,343
-92.9%
0.00%
-100.0%
Q2 2020$5,139,000
-20.2%
32,929
-26.2%
0.00%
-20.0%
Q1 2020$6,440,000
-8.4%
44,611
+29.7%
0.01%
+25.0%
Q4 2019$7,034,000
+95.1%
34,405
-23.4%
0.00%
+100.0%
Q3 2019$3,606,000
-20.3%
44,910
-6.4%
0.00%
-33.3%
Q2 2019$4,526,000
+284.9%
47,972
+248.7%
0.00%
+200.0%
Q1 2019$1,176,000
+119.0%
13,757
+43.5%
0.00%
Q4 2018$537,000
-7.1%
9,584
+35.5%
0.00%
Q3 2018$578,000
+1309.8%
7,073
+505.6%
0.00%
Q2 2018$41,000
-52.9%
1,168
-72.3%
0.00%
Q1 2018$87,000
-12.1%
4,216
+20.6%
0.00%
Q4 2017$99,000
-18.9%
3,496
-11.0%
0.00%
Q3 2017$122,000
+1933.3%
3,928
+1924.7%
0.00%
Q2 2017$6,000
+50.0%
194
+9.0%
0.00%
Q1 2017$4,000
-81.0%
178
-81.9%
0.00%
Q4 2016$21,000
+2000.0%
981
+2551.4%
0.00%
Q3 2016$1,000
-99.2%
37
-99.4%
0.00%
Q2 2016$120,0006,0840.00%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
DekaBank Deutsche Girozentrale 17,000$2,9300.01%
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO 93,711$1,6120.00%
IFP Advisors, Inc 300$51,7080.00%
View complete list of REATA PHARMACEUTICALS INC shareholders